Clinical Trial Update: Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone [Phase 3]

View source ↗

Summary

A phase 3 trial compared a triplet regimen of bortezomib, thalidomide, and dexamethasone to a bortezomib-dexamethasone doublet and to a bortezomib-melphalan-pre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Melphalan (Melphalan)
• PREDNISONE (Prednisone)
• Thalidomide (thalidomide)
• Velcade (bortezomib)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2014-05-01